[AVDL] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[AVDL] Avadel Pharmaceuticals plc
Announcement Date
08-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 43.70%
YoY- -80.06%
Quarter Report
AVDL's Result
AVDL's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 50,025 7,014 0 0 14,229 14,229 19,826 16.66%
PBT -2,537 -36,185 -20,076 -27,103 -16,743 -6,630 -16,462 -26.75%
Tax 88 89 70 -5,101 -5,040 2,234 -691 -
NP -2,625 -36,274 -20,146 -22,002 -11,703 -8,864 -15,771 -25.81%
Tax Rate - - - - - - - -
Total Cost 52,650 43,288 20,146 22,002 25,932 23,093 35,597 6.73%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -5.25 -517.17 0.00 0.00 -82.25 -62.30 -79.55 -36.40%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.03 -0.41 -0.33 -0.38 -0.20 -0.24 -0.43 -35.81%
EPS Diluted -0.03 -0.41 -0.33 -0.38 -0.20 -0.24 -0.43 -35.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.